|Slideshows|June 28, 2019

5 How-to articles for the pediatrician

You're a busy person with many things to do and little time to read. Here are 5 articles that give you a quick rundown of important matters for the pediatric provider.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe

Related Content

Douglas Mack, MD, says THRIVE study could change early peanut allergy management

ByDouglas Mack, MD, MSc, FRCPC

July 10th 2026

ACIP dropped MMRV coverage. New data show it was a lifeline for VFC-eligible kids

ByMorgan Ebert, Executive Editor

July 10th 2026

Infliximab and adalimumab show comparable infection risk in pediatric IBD

ByMorgan Ebert, Executive Editor

July 10th 2026

Douglas Mack, MD, shares details on the ongoing THRIVE study of epicutaneous immunotherapy for peanut allergy

ByDouglas Mack, MD, MSc, FRCPC

July 9th 2026

FDA grants rare pediatric disease designation to VCA-894A for Charcot-Marie-Tooth disease

July 9th 2026

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

5 How-to articles for the pediatrician

Related Content

Douglas Mack, MD, says THRIVE study could change early peanut allergy management

ACIP dropped MMRV coverage. New data show it was a lifeline for VFC-eligible kids

Infliximab and adalimumab show comparable infection risk in pediatric IBD

Douglas Mack, MD, shares details on the ongoing THRIVE study of epicutaneous immunotherapy for peanut allergy

FDA grants rare pediatric disease designation to VCA-894A for Charcot-Marie-Tooth disease

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

FAQ: Which children with early puberty actually need testing and treatment?

Douglas Mack, MD, shares details on the ongoing THRIVE study of epicutaneous immunotherapy for peanut allergy

FDA grants tegacorat orphan, rare pediatric disease status for DMD

ACIP dropped MMRV coverage. New data show it was a lifeline for VFC-eligible kids

Researchers identify hypermobility-linked autonomic subtype of eosinophilic esophagitis in children